nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—SLC6A4—panic disorder	0.487	0.565	CbGaD
Fluoxetine—HTR2A—panic disorder	0.374	0.434	CbGaD
Fluoxetine—SLC6A2—locus ceruleus—panic disorder	0.0109	0.155	CbGeAlD
Fluoxetine—SLC6A2—sympathetic nervous system—panic disorder	0.00859	0.123	CbGeAlD
Fluoxetine—ORM1—saliva—panic disorder	0.00752	0.107	CbGeAlD
Fluoxetine—HTR2A—locus ceruleus—panic disorder	0.00653	0.0932	CbGeAlD
Fluoxetine—SLC6A2—autonomic nervous system—panic disorder	0.00578	0.0824	CbGeAlD
Fluoxetine—HTR2A—sympathetic nervous system—panic disorder	0.00516	0.0737	CbGeAlD
Fluoxetine—HTR2A—vagus nerve—panic disorder	0.005	0.0714	CbGeAlD
Fluoxetine—SLC6A4—Serotonin Transporter Activity—TPH2—panic disorder	0.00411	0.0639	CbGpPWpGaD
Fluoxetine—HTR2A—autonomic nervous system—panic disorder	0.00347	0.0495	CbGeAlD
Fluoxetine—HTR2A—peripheral nervous system—panic disorder	0.0025	0.0357	CbGeAlD
Fluoxetine—SLC6A4—Serotonin Transporter Activity—MAOA—panic disorder	0.00247	0.0385	CbGpPWpGaD
Fluoxetine—HTR2C—Serotonin receptors—HTR1A—panic disorder	0.0022	0.0342	CbGpPWpGaD
Fluoxetine—HTR2A—Serotonin receptors—HTR1A—panic disorder	0.00191	0.0297	CbGpPWpGaD
Fluoxetine—HTR2C—Serotonin receptors—HTR7—panic disorder	0.00186	0.0289	CbGpPWpGaD
Fluoxetine—SLC6A4—Monoamine Transport—TPH2—panic disorder	0.00175	0.0272	CbGpPWpGaD
Fluoxetine—HTR2C—brainstem—panic disorder	0.00167	0.0238	CbGeAlD
Fluoxetine—SLC6A4—Monoamine Transport—ADORA2A—panic disorder	0.00167	0.026	CbGpPWpGaD
Fluoxetine—HTR2A—Serotonin receptors—HTR7—panic disorder	0.00161	0.0251	CbGpPWpGaD
Fluoxetine—SLC6A4—brainstem—panic disorder	0.00158	0.0226	CbGeAlD
Fluoxetine—Duloxetine—SLC6A4—panic disorder	0.00154	0.371	CrCbGaD
Fluoxetine—SLC6A2—Monoamine Transport—TPH2—panic disorder	0.0015	0.0234	CbGpPWpGaD
Fluoxetine—SLC6A2—Monoamine Transport—ADORA2A—panic disorder	0.00143	0.0223	CbGpPWpGaD
Fluoxetine—SLC6A2—brainstem—panic disorder	0.00139	0.0199	CbGeAlD
Fluoxetine—HTR2C—Serotonin receptors—HTR2A—panic disorder	0.0013	0.0203	CbGpPWpGaD
Fluoxetine—SLC6A2—Monoamine Transport—SLC6A4—panic disorder	0.0012	0.0187	CbGpPWpGaD
Fluoxetine—Duloxetine—HTR2A—panic disorder	0.00119	0.285	CrCbGaD
Fluoxetine—HTR2C—midbrain—panic disorder	0.00106	0.0152	CbGeAlD
Fluoxetine—SLC6A4—midbrain—panic disorder	0.00101	0.0144	CbGeAlD
Fluoxetine—SIGMAR1—midbrain—panic disorder	0.001	0.0143	CbGeAlD
Fluoxetine—HTR2C—Monoamine GPCRs—HTR1A—panic disorder	0.000978	0.0152	CbGpPWpGaD
Fluoxetine—HTR2C—Monoamine GPCRs—ADRA2A—panic disorder	0.0009	0.014	CbGpPWpGaD
Fluoxetine—HTR2C—Serotonin Receptor 2 and ELK-SRF/GATA4 signaling—HTR2A—panic disorder	0.000865	0.0135	CbGpPWpGaD
Fluoxetine—HTR2A—Monoamine GPCRs—HTR1A—panic disorder	0.00085	0.0132	CbGpPWpGaD
Fluoxetine—HTR2A—brainstem—panic disorder	0.000838	0.012	CbGeAlD
Fluoxetine—HTR2C—Monoamine GPCRs—HTR7—panic disorder	0.000828	0.0129	CbGpPWpGaD
Fluoxetine—HTR2C—Amine ligand-binding receptors—HTR1A—panic disorder	0.000822	0.0128	CbGpPWpGaD
Fluoxetine—CYP1A2—Methylation—COMT—panic disorder	0.000812	0.0126	CbGpPWpGaD
Fluoxetine—Atomoxetine—SLC6A4—panic disorder	0.000808	0.194	CrCbGaD
Fluoxetine—HTR2A—Monoamine GPCRs—ADRA2A—panic disorder	0.000781	0.0122	CbGpPWpGaD
Fluoxetine—CYP2D6—brainstem—panic disorder	0.000764	0.0109	CbGeAlD
Fluoxetine—HTR2C—Amine ligand-binding receptors—ADRA2A—panic disorder	0.000756	0.0118	CbGpPWpGaD
Fluoxetine—HTR2A—Monoamine GPCRs—HTR7—panic disorder	0.000719	0.0112	CbGpPWpGaD
Fluoxetine—HTR2A—Amine ligand-binding receptors—HTR1A—panic disorder	0.000714	0.0111	CbGpPWpGaD
Fluoxetine—HTR2C—Amine ligand-binding receptors—HTR7—panic disorder	0.000696	0.0108	CbGpPWpGaD
Fluoxetine—HTR2C—brain—panic disorder	0.000669	0.00955	CbGeAlD
Fluoxetine—HTR2A—Amine ligand-binding receptors—ADRA2A—panic disorder	0.000657	0.0102	CbGpPWpGaD
Fluoxetine—ALB—brain—panic disorder	0.000653	0.00932	CbGeAlD
Fluoxetine—SLC6A4—brain—panic disorder	0.000634	0.00905	CbGeAlD
Fluoxetine—SIGMAR1—brain—panic disorder	0.00063	0.00899	CbGeAlD
Fluoxetine—Atomoxetine—HTR2A—panic disorder	0.000621	0.149	CrCbGaD
Fluoxetine—HTR2A—Amine ligand-binding receptors—HTR7—panic disorder	0.000604	0.0094	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Other—CCKBR—panic disorder	0.000602	0.00936	CbGpPWpGaD
Fluoxetine—HTR2C—Monoamine GPCRs—HTR2A—panic disorder	0.00058	0.00902	CbGpPWpGaD
Fluoxetine—SLC6A2—brain—panic disorder	0.000558	0.00797	CbGeAlD
Fluoxetine—HTR2A—midbrain—panic disorder	0.000534	0.00762	CbGeAlD
Fluoxetine—CYP1A2—Estrogen metabolism—COMT—panic disorder	0.000507	0.00789	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—TPH2—panic disorder	0.000492	0.00766	CbGpPWpGaD
Fluoxetine—HTR2C—Amine ligand-binding receptors—HTR2A—panic disorder	0.000487	0.00758	CbGpPWpGaD
Fluoxetine—CYP2C19—Melatonin metabolism and effects—MAOA—panic disorder	0.000441	0.00687	CbGpPWpGaD
Fluoxetine—HTR2C—G alpha (q) signalling events—NPSR1—panic disorder	0.000437	0.0068	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Other—ADORA2A—panic disorder	0.000435	0.00677	CbGpPWpGaD
Fluoxetine—CYP2B6—brain—panic disorder	0.000412	0.00587	CbGeAlD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—HTR1A—panic disorder	0.000407	0.00634	CbGpPWpGaD
Fluoxetine—CYP2D6—Melatonin metabolism and effects—MAOA—panic disorder	0.000406	0.00632	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—TPH2—panic disorder	0.000402	0.00625	CbGpPWpGaD
Fluoxetine—CYP3A4—Estrogen metabolism—COMT—panic disorder	0.000391	0.00609	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—NPSR1—panic disorder	0.000391	0.00608	CbGpPWpGaD
Fluoxetine—HTR2C—G alpha (q) signalling events—CCKBR—panic disorder	0.000389	0.00606	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—ADORA2A—panic disorder	0.000383	0.00597	CbGpPWpGaD
Fluoxetine—HTR2A—G alpha (q) signalling events—NPSR1—panic disorder	0.000379	0.0059	CbGpPWpGaD
Fluoxetine—SLC6A2—NRF2 pathway—SLC6A4—panic disorder	0.000357	0.00555	CbGpPWpGaD
Fluoxetine—ABCB1—midbrain—panic disorder	0.00035	0.005	CbGeAlD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—panic disorder	0.000348	0.00542	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—CRH—panic disorder	0.000346	0.00538	CbGpPWpGaD
Fluoxetine—CYP1A2—Melatonin metabolism and effects—MAOA—panic disorder	0.000344	0.00535	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—NPSR1—panic disorder	0.000339	0.00528	CbGpPWpGaD
Fluoxetine—HTR2A—G alpha (q) signalling events—CCKBR—panic disorder	0.000338	0.00526	CbGpPWpGaD
Fluoxetine—HTR2A—brain—panic disorder	0.000336	0.00479	CbGeAlD
Fluoxetine—HTR2C—G alpha (q) signalling events—RGS2—panic disorder	0.000335	0.00521	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Other—HTR7—panic disorder	0.000319	0.00497	CbGpPWpGaD
Fluoxetine—CYP2D6—brain—panic disorder	0.000306	0.00436	CbGeAlD
Fluoxetine—HTR2C—G alpha (q) signalling events—CCK—panic disorder	0.000303	0.00471	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CCKBR—panic disorder	0.000302	0.00471	CbGpPWpGaD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000301	0.00468	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—panic disorder	0.000299	0.00466	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—TPH2—panic disorder	0.000296	0.00461	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—MAOA—panic disorder	0.000296	0.00461	CbGpPWpGaD
Fluoxetine—HTR2A—G alpha (q) signalling events—RGS2—panic disorder	0.000291	0.00453	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000289	0.0045	CbGpPWpGaD
Fluoxetine—SLC6A4—Circadian rythm related genes—HTR7—panic disorder	0.000281	0.00438	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—panic disorder	0.000271	0.00422	CbGpPWpGaD
Fluoxetine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.000265	0.00412	CbGpPWpGaD
Fluoxetine—HTR2A—G alpha (q) signalling events—CCK—panic disorder	0.000263	0.00409	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—CCKBR—panic disorder	0.000261	0.00407	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RGS2—panic disorder	0.00026	0.00405	CbGpPWpGaD
Fluoxetine—CYP3A5—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.000259	0.00403	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000258	0.00401	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—NPSR1—panic disorder	0.000251	0.00391	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—HTR1A—panic disorder	0.000245	0.00382	CbGpPWpGaD
Fluoxetine—SLC6A4—SIDS Susceptibility Pathways—HTR2A—panic disorder	0.000241	0.00376	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—SLC6A4—panic disorder	0.000237	0.00369	CbGpPWpGaD
Fluoxetine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—CCK—panic disorder	0.000235	0.00366	CbGpPWpGaD
Fluoxetine—ALB—FOXA2 and FOXA3 transcription factor networks—INS—panic disorder	0.000228	0.00355	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCKBR—panic disorder	0.000224	0.00349	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—NPSR1—panic disorder	0.00022	0.00343	CbGpPWpGaD
Fluoxetine—ABCB1—brain—panic disorder	0.00022	0.00314	CbGeAlD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000218	0.00339	CbGpPWpGaD
Fluoxetine—ALB—Vitamin B12 Metabolism—INS—panic disorder	0.000203	0.00315	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000201	0.00312	CbGpPWpGaD
Fluoxetine—CYP2C19—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.0002	0.00311	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CCKBR—panic disorder	0.000196	0.00306	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—NPSR1—panic disorder	0.000191	0.00298	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—ADORA2A—panic disorder	0.000189	0.00294	CbGpPWpGaD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.000189	0.00294	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000186	0.0029	CbGpPWpGaD
Fluoxetine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.000184	0.00286	CbGpPWpGaD
Fluoxetine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.000182	0.00284	CbGpPWpGaD
Fluoxetine—HTR2A—SIDS Susceptibility Pathways—MAOA—panic disorder	0.000178	0.00277	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—CCK—panic disorder	0.000174	0.00271	CbGpPWpGaD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.000174	0.0027	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CCKBR—panic disorder	0.000171	0.00265	CbGpPWpGaD
Fluoxetine—ALB—Folate Metabolism—INS—panic disorder	0.000165	0.00257	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR1A—panic disorder	0.000164	0.00255	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADORA2A—panic disorder	0.000162	0.00252	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.000162	0.00252	CbGpPWpGaD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.00016	0.00249	CbGpPWpGaD
Fluoxetine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.000156	0.00243	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CCK—panic disorder	0.000153	0.00238	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—ADRA2A—panic disorder	0.000151	0.00235	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	0.000149	0.00231	CbGpPWpGaD
Fluoxetine—HTR2C—G alpha (q) signalling events—HTR2A—panic disorder	0.000145	0.00225	CbGpPWpGaD
Fluoxetine—CYP1A2—Phase II conjugation—COMT—panic disorder	0.000143	0.00222	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—ADORA2A—panic disorder	0.000142	0.00221	CbGpPWpGaD
Fluoxetine—CYP2B6—Biological oxidations—COMT—panic disorder	0.000142	0.0022	CbGpPWpGaD
Fluoxetine—CYP2B6—Biological oxidations—MAOA—panic disorder	0.000141	0.00219	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR1A—panic disorder	0.00014	0.00219	CbGpPWpGaD
Fluoxetine—CYP2B6—Metapathway biotransformation—COMT—panic disorder	0.00014	0.00217	CbGpPWpGaD
Fluoxetine—HTR2A—GPCRs, Class A Rhodopsin-like—HTR7—panic disorder	0.000139	0.00216	CbGpPWpGaD
Fluoxetine—CYP3A5—Biological oxidations—COMT—panic disorder	0.000138	0.00215	CbGpPWpGaD
Fluoxetine—CYP3A5—Biological oxidations—MAOA—panic disorder	0.000137	0.00214	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	0.000137	0.00213	CbGpPWpGaD
Fluoxetine—CYP3A5—Metapathway biotransformation—COMT—panic disorder	0.000136	0.00212	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CCK—panic disorder	0.000133	0.00206	CbGpPWpGaD
Fluoxetine—ALB—Selenium Micronutrient Network—INS—panic disorder	0.000131	0.00204	CbGpPWpGaD
Fluoxetine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—panic disorder	0.000129	0.00201	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ADRA2A—panic disorder	0.000129	0.00201	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—CRH—panic disorder	0.000128	0.00199	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—NPSR1—panic disorder	0.000125	0.00194	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—ADORA2A—panic disorder	0.000123	0.00192	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—HTR1A—panic disorder	0.000123	0.00192	CbGpPWpGaD
Fluoxetine—ALB—Platelet activation, signaling and aggregation—ADRA2A—panic disorder	0.000123	0.00191	CbGpPWpGaD
Fluoxetine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—panic disorder	0.00012	0.00187	CbGpPWpGaD
Fluoxetine—HTR2A—Class A/1 (Rhodopsin-like receptors)—HTR7—panic disorder	0.000119	0.00185	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—ADRA2A—panic disorder	0.000113	0.00176	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—NPSR1—panic disorder	0.000113	0.00176	CbGpPWpGaD
Fluoxetine—HTR2C—GPCRs, Class A Rhodopsin-like—HTR2A—panic disorder	0.000112	0.00174	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—CRH—panic disorder	0.000111	0.00173	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCKBR—panic disorder	0.000111	0.00173	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—NPSR1—panic disorder	0.000108	0.00168	CbGpPWpGaD
Fluoxetine—CYP2C19—Biological oxidations—COMT—panic disorder	0.000107	0.00167	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—HTR1A—panic disorder	0.000107	0.00166	CbGpPWpGaD
Fluoxetine—CYP2C19—Biological oxidations—MAOA—panic disorder	0.000106	0.00165	CbGpPWpGaD
Fluoxetine—CYP2C19—Metapathway biotransformation—COMT—panic disorder	0.000106	0.00164	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—HTR7—panic disorder	0.000104	0.00162	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCKBR—panic disorder	0.000101	0.00157	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—COMT—panic disorder	9.84e-05	0.00153	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—ADRA2A—panic disorder	9.84e-05	0.00153	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—NPSR1—panic disorder	9.82e-05	0.00153	CbGpPWpGaD
Fluoxetine—CYP2D6—Biological oxidations—MAOA—panic disorder	9.77e-05	0.00152	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—COMT—panic disorder	9.76e-05	0.00152	CbGpPWpGaD
Fluoxetine—CYP2D6—Metapathway biotransformation—COMT—panic disorder	9.71e-05	0.00151	CbGpPWpGaD
Fluoxetine—CYP2C9—Biological oxidations—MAOA—panic disorder	9.69e-05	0.00151	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCKBR—panic disorder	9.64e-05	0.0015	CbGpPWpGaD
Fluoxetine—CYP2C9—Metapathway biotransformation—COMT—panic disorder	9.62e-05	0.0015	CbGpPWpGaD
Fluoxetine—HTR2C—Class A/1 (Rhodopsin-like receptors)—HTR2A—panic disorder	9.58e-05	0.00149	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—RGS2—panic disorder	9.54e-05	0.00149	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR ligand binding—HTR7—panic disorder	9.05e-05	0.00141	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCKBR—panic disorder	8.75e-05	0.00136	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—RGS2—panic disorder	8.67e-05	0.00135	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CCK—panic disorder	8.63e-05	0.00134	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—COMT—panic disorder	8.34e-05	0.0013	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—RGS2—panic disorder	8.29e-05	0.00129	CbGpPWpGaD
Fluoxetine—CYP1A2—Biological oxidations—MAOA—panic disorder	8.28e-05	0.00129	CbGpPWpGaD
Fluoxetine—CYP1A2—Metapathway biotransformation—COMT—panic disorder	8.22e-05	0.00128	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—ADORA2A—panic disorder	8.02e-05	0.00125	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CCK—panic disorder	7.84e-05	0.00122	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—RGS2—panic disorder	7.53e-05	0.00117	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CCK—panic disorder	7.49e-05	0.00117	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR ligand binding—HTR2A—panic disorder	7.3e-05	0.00114	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—ADORA2A—panic disorder	7.29e-05	0.00113	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—CRH—panic disorder	7.23e-05	0.00113	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—ADORA2A—panic disorder	6.97e-05	0.00108	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR1A—panic disorder	6.96e-05	0.00108	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CCK—panic disorder	6.81e-05	0.00106	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—NPSR1—panic disorder	6.68e-05	0.00104	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—CRH—panic disorder	6.57e-05	0.00102	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—COMT—panic disorder	6.43e-05	0.001	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—ADRA2A—panic disorder	6.4e-05	0.000996	CbGpPWpGaD
Fluoxetine—CYP3A4—Biological oxidations—MAOA—panic disorder	6.39e-05	0.000994	CbGpPWpGaD
Fluoxetine—CYP3A4—Metapathway biotransformation—COMT—panic disorder	6.35e-05	0.000988	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ADORA2A—panic disorder	6.33e-05	0.000985	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR1A—panic disorder	6.32e-05	0.000984	CbGpPWpGaD
Fluoxetine—ALB—Hemostasis—ADRA2A—panic disorder	6.31e-05	0.000983	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—CRH—panic disorder	6.28e-05	0.000977	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—HTR1A—panic disorder	6.05e-05	0.000941	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCKBR—panic disorder	5.95e-05	0.000927	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR7—panic disorder	5.89e-05	0.000917	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—ADRA2A—panic disorder	5.81e-05	0.000905	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—NPSR1—panic disorder	5.8e-05	0.000903	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—CRH—panic disorder	5.7e-05	0.000888	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—ADRA2A—panic disorder	5.56e-05	0.000865	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HTR1A—panic disorder	5.49e-05	0.000854	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR7—panic disorder	5.35e-05	0.000832	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCKBR—panic disorder	5.17e-05	0.000805	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—RGS2—panic disorder	5.12e-05	0.000797	CbGpPWpGaD
Fluoxetine—HTR2A—GPCR downstream signaling—HTR7—panic disorder	5.11e-05	0.000796	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—ADRA2A—panic disorder	5.05e-05	0.000786	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling by GPCR—HTR7—panic disorder	4.64e-05	0.000723	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CCK—panic disorder	4.63e-05	0.000721	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—RGS2—panic disorder	4.45e-05	0.000692	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADORA2A—panic disorder	4.3e-05	0.00067	CbGpPWpGaD
Fluoxetine—HTR2C—GPCR downstream signaling—HTR2A—panic disorder	4.12e-05	0.000642	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CCK—panic disorder	4.02e-05	0.000626	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—TPH2—panic disorder	4e-05	0.000622	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—TPH2—panic disorder	3.91e-05	0.000608	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—CRH—panic disorder	3.88e-05	0.000604	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling by GPCR—HTR2A—panic disorder	3.75e-05	0.000583	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADORA2A—panic disorder	3.74e-05	0.000582	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR1A—panic disorder	3.73e-05	0.000581	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—ADRA2A—panic disorder	3.43e-05	0.000534	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—CRH—panic disorder	3.37e-05	0.000524	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—TPH2—panic disorder	3.36e-05	0.000524	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR1A—panic disorder	3.24e-05	0.000505	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR7—panic disorder	3.16e-05	0.000492	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—ADRA2A—panic disorder	3.04e-05	0.000473	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—TPH2—panic disorder	3.02e-05	0.00047	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—ADRA2A—panic disorder	2.98e-05	0.000464	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—ADRA2A—panic disorder	2.97e-05	0.000463	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—TPH2—panic disorder	2.95e-05	0.000459	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—TPH2—panic disorder	2.78e-05	0.000432	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—TPH2—panic disorder	2.75e-05	0.000429	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—HTR7—panic disorder	2.74e-05	0.000427	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—ADRA2A—panic disorder	2.56e-05	0.000398	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—COMT—panic disorder	2.42e-05	0.000377	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—MAOA—panic disorder	2.4e-05	0.000374	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—COMT—panic disorder	2.37e-05	0.000368	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—TPH2—panic disorder	2.35e-05	0.000366	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—MAOA—panic disorder	2.35e-05	0.000366	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—ADRA2A—panic disorder	2.3e-05	0.000358	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—ADRA2A—panic disorder	2.24e-05	0.000349	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—HTR2A—panic disorder	2.21e-05	0.000344	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—ADRA2A—panic disorder	2.11e-05	0.000329	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—ADRA2A—panic disorder	2.1e-05	0.000326	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—COMT—panic disorder	2.04e-05	0.000317	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—MAOA—panic disorder	2.02e-05	0.000315	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—COMT—panic disorder	1.83e-05	0.000285	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—MAOA—panic disorder	1.82e-05	0.000283	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—TPH2—panic disorder	1.82e-05	0.000283	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—ADRA2A—panic disorder	1.79e-05	0.000279	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—COMT—panic disorder	1.79e-05	0.000278	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—MAOA—panic disorder	1.77e-05	0.000276	CbGpPWpGaD
Fluoxetine—HTR2C—Signaling Pathways—INS—panic disorder	1.76e-05	0.000274	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—COMT—panic disorder	1.68e-05	0.000262	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—MAOA—panic disorder	1.67e-05	0.00026	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—COMT—panic disorder	1.67e-05	0.00026	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—MAOA—panic disorder	1.66e-05	0.000258	CbGpPWpGaD
Fluoxetine—CYP2B6—Metabolism—INS—panic disorder	1.56e-05	0.000242	CbGpPWpGaD
Fluoxetine—HTR2A—Signaling Pathways—INS—panic disorder	1.53e-05	0.000238	CbGpPWpGaD
Fluoxetine—CYP3A5—Metabolism—INS—panic disorder	1.52e-05	0.000237	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—COMT—panic disorder	1.43e-05	0.000222	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—MAOA—panic disorder	1.42e-05	0.00022	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—ADRA2A—panic disorder	1.38e-05	0.000215	CbGpPWpGaD
Fluoxetine—ALB—Metabolism—INS—panic disorder	1.31e-05	0.000204	CbGpPWpGaD
Fluoxetine—CYP2C19—Metabolism—INS—panic disorder	1.18e-05	0.000183	CbGpPWpGaD
Fluoxetine—ABCB1—Metabolism—INS—panic disorder	1.15e-05	0.000179	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—COMT—panic disorder	1.1e-05	0.000171	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—MAOA—panic disorder	1.09e-05	0.00017	CbGpPWpGaD
Fluoxetine—CYP2D6—Metabolism—INS—panic disorder	1.08e-05	0.000168	CbGpPWpGaD
Fluoxetine—CYP2C9—Metabolism—INS—panic disorder	1.07e-05	0.000167	CbGpPWpGaD
Fluoxetine—CYP1A2—Metabolism—INS—panic disorder	9.17e-06	0.000143	CbGpPWpGaD
Fluoxetine—CYP3A4—Metabolism—INS—panic disorder	7.07e-06	0.00011	CbGpPWpGaD
